Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3561 180 0
Emcee:  dalroi Type:  Moderated
this forum is for firesale alerts

stock need to drop more then 15% in 1 day
1/ dont spam on this board
2/ if in the next days it doesnt drop 15% discuss it somewhere else

reversals are ok as long as the post is made around the 15% droppoint

try to give a reason why it did it and use the ticker in headline

mean reason for this board IS ALLERTING so one knows there is something going on
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3561SYRS Given the persistence of prior price trends, I think that was just the begituck-June 22
3560Given the persistence of prior price trends, I think that was just the beginningsemi_infinite -June 22
3559Syros (SYRS) was off over 17% yesterday on decent volume and no news. I was shotuck-June 22
3558yes, congrats to SRPT holders: as long as Tuck injected SRPT in his firesale thquidditch-June 19
3557Also, given the implications for Translarna, PTCT is down 15+% now. Good thingtuck-June 19
3556Congrat. to all SRPT SH!Miljenko Zuanic-June 19
3555Wave LifeSciences (WVE) off 18% on strong data from a competitor (Sarepta). Chetuck-June 19
3554CBIO closes -64%. I listened to the CC this morning and thought the company hanDewDiligence_on_SI1June 18
3553CYTK -16% on P2 announcementmopgcw-June 18
3552Disclaimer: After missing initial rise in NKTR share price, and after decline (Miljenko Zuanic-June 4
3551In light of the ASCO debacle/euphoric cases: my Q is what dictate those,... knowMiljenko Zuanic-June 4
3550CytomX another ASCO loser, now 17%, on sketchy data for CX-072. P1 across many tuck1June 4
3549Jounce (JNCE) a two time ASCO loser, as updated data presented yesterday seems etuck-June 4
3548 Nektar down 24% premarket on Opdivo + NKTR-214 data Nektar Therapeutics (NASDAJulius Wong1June 4
3547SNDX -22% on tepid data from ENCORE-601 study: investorshub.advfn.comDewDiligence_on_SI-May 17
3546Jounce (JNCE) the main ASCO loser, off 25% after hours on underwhelming responsetuck-May 16
3545EOLS -31% on CRL that shouldn’t have been a surprise to anybody (but evidently wDewDiligence_on_SI1May 16
3544Aw, shucks . . . anyhow, as is sometimes the case, the AdCom wasn't tuck-May 10
3543 Thanks, as always, for the synopsis.scaram(o)uche-May 8
3542Akcea (AKCA), the IONS spinoff, off 16% after briefing docs come out with a prettuck-May 8
3541Achaogen (AKAO) off 26% on negative AdCom vote for Plazomicin in blood stream intuck-May 3
3540VTVT has a couple of programs in T2D that are nothing special, IMO. DewDiligence_on_SI-April 9
3539Speaking of not seeing effective AD treatments in my lifetime . . . VTVtuck1April 9
3538reading that brings back very sad memories.semi_infinite -April 9
3537Here is the link to the ACAD response to CNN, with some facts. Gottlieb also caBiotech Jim1April 9
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2018 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.